Acute kidney injury (AKI) is a serious complication in the perioperative period and is consistently associated with increased morbidity and case fatality rate. This has been best studied in the cardiac surgery setting where it has been shown that up to 11.5-86% of patients exposed to cardiopulmonary bypass (CPB) will develop AKI, with 2-18.9% requiring renal replacement therapy (RRT). Depending on the criteria used to define AKI and the postoperative period studied, mortality ranges from 1% to 30%, although this is consistently higher, approaching 80%, if RRT is required. AKI may contribute to chronic kidney disease and negative long-term health outcomes. There is no clear understanding of the pathogenesis of CPB associated AKI and no effective treatment or prevention has yet been established for this 
INTRODUCTION
syndrome. Fluid overload (FO), which often accompanies significant AKI, was first recognised in a retrospective study of paediatric bone marrow transplant patients (Lane et al., 1994) . Studies of adult critically ill patients have shown that positive FB above 10% is associated with higher long-term mortality and higher occurrence of AKI, thus indicating this threshold as a potential indicator of adverse outcome (Van Biesen et al. 2005) . The study of Hassinger et al. showed that patients with early positive FB, more than 5% by the end of POD 1, were more likely to develop AKI (43.3% vs 33.8%, p = 0.023). The authors also observed that positive FB was associated with a prolonged lengths of hospital stay (3.5 more days in the hospital), two more days on inotropes, and increased prevalence of prolonged mechanical ventilation (Hassinger et al., 2014) .
MATERIALS AND METHODS
Children undergoing elective CPB for surgical correction or palliation of congenital heart lesions between January 2011 and June 2015 were prospectively enrolled. Exclusion criteria included preexisting renal dysfunction. Renal dysfunction was defined as a SCr level that was greater than the 90th percentile for the child's age and gender. Patients with a history of potential nephrotoxin use during the preoperative day were excluded because of potential confounding effects. Ethical approval was obtained from the Ethics Committee of the Children's Clinical University Hospital.
Creatinine concentrations were measured in the hospital's clinical chemical laboratory using Jaffes method on a Cobas 8000 analyser. The primary outcome variable was the development of AKI. AKI was defined according to the KDIGO classification and staging system based on urine output and SCr level: Stage I was SCr 1.5-1.9 times baseline ³ 26.5 µmol/L increase or UO < 0.5 ml/kg/h for 6-12 hours, stage II was SCr 2-2.9 times baseline and UO < 0.5 ml/kg/h for ³ 12 hours, stage III was SCr 3 times baseline or ³ 354 µmol/L and/or UO < 0.3 ml/kg/h for ³ 24 hours OR anuria for ³ 12 hours (Kellum et al., 2012) .
Intraoperative fluid intake was assessed by total of intravenous fluid volume, cardioplegia volume, and pump volume (total volume added during cardiopulmonary bypass plus reservoir volume at the start of cardiopulmonary bypass minus reservoir volume at the termination of cardiopulmonary bypass). Intraoperative fluid output was the total of urine produced on cardiopulmonary bypass, chest tube drainage before the patient left the operating room, and estimated blood loss. Intraoperative net fluid balance was the difference between fluid intake and output. Data for further processing were retrieved from anaesthesia and intensive care data management IntelliView Clinical Information Portfolio (Philips) system flowsheets ( Fig. 1) . Similarly, fluid balance was calculated after the completion of surgical repair. Patient data were collected from day of admission to Intensive care (denoted as POD-1).
Sample collection and processing. Creatinine concentrations were measured in the hospital's clinical chemical laboratory by Jaffes method on a Cobas 8000 analyser. All samples were obtained at the following time points: (1) preoperative; (2) 24 hours and (3) 48 hours after the surgical repair. The primary outcome variable was the development of AKI. AKI was defined according to the KDIGO classification and staging system based on urine output and SCr level: Stage I was SCr 1.5-1.9 times baseline ³ 26.5 µmol/L increase or UO < 0.5 ml/kg/h for 6-12 hours, stage II was SCr 2-2.9 times baseline and UO < 0.5 ml/kg/h for ³ 12 hours, stage III was SCr 3 times baseline or ³ 354 µmol/l and/or UO 0.3 ml/kg/h for ³ 24 hours OR anuria for ³ 12 hours (Kellum et al., 2012) . Recorded variables included age, gender, CPB time, lowest temperature during CPB and urine output, doses of diuretics, inotropes and vasopressors, and postoperative fluid balance. Outcome variables included percent change in serum creatinine, days in AKI, dialysis requirement, duration of MV, lengths of stay in ICU and hospital LOS.
Anaesthesia management. Induction to anaesthesia was provided using inhalation of Sevoflurane by face mask or intravenously by Propofol or Midazolam in combination with Ketamine. Anaesthesia was maintained at (0.8-1.0 minimal alveolar concentration) of sevoflurane and fentanyl (3-5 µg kg/h) using a Primus anaesthesia machine (Drãger Medical, Lübeck, Germany). Muscle relaxation was achieved with pipecuronium (0.6 mg/kg). During CPB, isoflurane was applied via the CPB circuit. All patients were ventilated in a volume-controlled mode; with a tidal volume of 6 ml/kg and respiratory rate adjusted to achieve normocapnia. The heart-lung machine SORIN S 5 (LivaNova, United Kingdom) with a membrane oxygenator Affinity Pixie ® Oxygenatior (Medrtronics, USA) was used for neonates, infants and small children requiring cardiopulmonary bypass at flow rates up to 2.0 L/min. For older patients Terumo, Medtronic C oxygenator with CPB circuit was used. Surgical procedures were performed with CPB in moderate hypothermia. Cardioplegic arrest was achieved by cold blood cardioplegia and repeated every 20 minutes. Nonpulsatile perfusion was performed during CPB. Pump flow, oxygen flow, and MAP were adjusted to maintain ScvO 2 levels within the preoperative range and at least higher than 50% absolute. In patients monitored with a pulmonary artery catheter (PAC), haemodynamic therapy was titrated to achieve car- diac index > 2.2 L/min/m2 and mixed venous oxygen saturation (Sv O 2 ) greater than 65%.
Fluid therapy was performed with balanced crystalloid (Lactated Ringers solution, Sterofundin VG, BBraun; Melsungen, Germany). The pump prime consisted of various amounts of Ringer lactate and whole blood, depending on estimated blood volume, haematocrit, and total priming volume used. Hypothermic myocardial protection was provided by core cooling at flow rates of 150 to 200 ml/kg/ min. (2.0 to 3.0 kg) or 100 to 150 ml/kg/min. (3.0 to 5.0 kg) to rectal and esophageal temperatures of £ 30°C, followed by aortic cross clamping. Once optimal hypothermic temperatures were reached, continuous low-flow cardiopulmonary bypass was instituted during completion of intracardiac stage. Core rewarming was instituted during completion of the intracardial stage. Mean perfusion pressures were maintained between 30 mm Hg and 70 mm Hg during rewarming. All patients were weaned from cardiopulmonary bypass after the rectal temperature reached 35°C. Lactated Ringers, fresh whole blood, blood products, and increased inotropic support were given as necessary to maintain normal filling pressures and a systolic perfusion pressure of at least 60 mm Hg.
Postoperative management. Analgesia and sedation were provided by a continuous fentanyl or morphine infusion, typically 2-4 µg kg -1 ·h -1 and Midazolam or Dexmedetomidine. Routine continuous postoperative monitoring included the surface ECG, transcutaneous pulse oximetry, pulmonary arterial and right and left atrial pressures (through transthoracic catheters), and systemic arterial pressure. Inotropic, chronotropic, and afterload reducing agents were used as clinically indicated. Vasoactive medications were typically started in the operating room at the discretion of the attending cardiac surgeon and anaesthesiologist based on individual patient characteristics, including, residual lesions, transesophageal echocardiographic findings, and physiological status. On arrival to the ICU, medications are adjusted by the bedside nurse under the direction of the ICU team. Patients with hypotension typically receive norepinephrine and epinephrine initially, volume infusions (plasma or 5% albumin) were given to maintain adequate filling pressures with systolic perfusion pressures of at least 50 mm Hg. Diuretics (usually furosemide 1 to 2 mg/kg per dose, two to four times daily) were prescribed at the attending physician's discretion if a targeted fluid balance or urine output of > 0.5 ml/kg/hour could not be achieved. Some patients received continuous infusion of Furosemide and Aminophilline.
During the study continuous fentanyl or morphine infusions were discontinued on the first postoperative morning in the haemodynamically stable patient or continued for longer periods as dictated by the clinical status of the patient. Mechanic ventilation was provided with a Viasys Avea ventilator (Cardinal Health, USA) at the mode suitable for specific cardiac lesion. The rate of weaning of mechanical ventilation was determined by the patient's fluid balance and gas exchange as indicated by arterial blood sampling, pattern of breathing, and daily radiographic findings.
The initial mode of ventilation was pressure-regulated volume control in all patients. Once the patient was breathing spontaneously and ready for weaning, the ventilator mode was switched to pressure-controlled, synchronised, intermittent, mandatory ventilation.
The criteria for extubation was protocolised, as follows: stable haemodynamic profile, normal cardiac rhythm, adequate oxygenation on fraction of inspired oxygen < 0. Variables with a probability value less than 0.1 were then cast into a multivariate logistic regression analysis. Odds ratio, CI, and probability values were calculated. All univariate and multivariate logistic regression analyses were conducted for the entire cohort. Receiver operating characteristics (ROC) curves were generated for the occurrence of AKI within 48 hours following cardiopulmonary bypass using FB at POD-1. The areas under the curve (AUC), with 95% confidence intervals (95% CI), were calculated. Also, the optimal cut-off value was calculated with corresponding sensitivity and specificity. Using those cut-off values, sensitivity and specificity of FB for predicting AKI were calculated for patients who developed AKI. Two-sided p = 0.05 was considered the limit of significance in all analyses. Data were analysed using IBM SPSS statistics version 21 (Statistical Package for the Social Sciences, Chicago, IL).
RESULTS
Median age of patients was ten months, and body weight was 7.6 kg ( Table 1 ). The majority from 93 included patients 54 (58.00%) were less than 12 months old, 6 patients (6.45%) were less than 1 months old, 20 (21.51%) patients were between 1 and 6 months of age; and 28 (30.11%) patients had age of 7 to 12 months were. Age group of 1 to 3 years represents 23 (24.73%) children. 6.45% were patients between 3 to 7 years, and 10.75% were older than 7 years, (Fig. 2 , Table 2 ). Types of congenital heart lesions are summarised in Table 3 .
Postoperative AKI occurred in 42 (45.16%) of 93 children. Thirty-seven of them reached severity stage I according the KDIGO classification and stating system, three reached stage II and two reached stage III, based on SCr and (or) urine output criteria (Fig. 3) . Fig. 4 shows changes in % from the baseline SCr concentration to maximum during 48 hours. It shows number of patients for each AKI severity stage.
Postoperative fluid balance (FB POD-1) was 13.58 ml/kg (median) in the non-AKI group versus 27.20 ml/kg in the AKI group, p = 0.025 (Fig. 5, Table 4 ). In addition, FB was calculated separately according the severity stage of AKI.
T a b l e 1 DEMOGRAPHIC DATA Fluid balance in patients reaching 1 st stage of AKI severity increased from 13.58 ml/kg (median) to 26.27 ml/kg, 2 nd stage to 36.29 ml/kg and 3 rd stage to 90.09 ml/kg, ANOVA test p = 0.002 (Fig. 6 ). To evaluate postoperative fluid balance as a marker for AKI, ROC analysis was performed (Fig. 7) . AUC was 0.842 (CI 95% 0.838-0.926), sensitivity of 80%, specificity of 71% and cut-off value of 25 ml/kg.
DISCUSSION
Studies of paediatric patients requiring RRT showed correlation of the degree of positive FB with poor outcome and mortality, hinting at a dynamic positive FB value for predicting adverse outcomes, with the 10% cut-off value proving to be clinically significant (Horiguchi et al., 2014) . Infants 72 hours after cardiac surgery with a positive fluid balance had 10 times higher odds of prolonged mechanical ventilation than infants without a positive fluid balance (Shi et al., 2008) . Patients with ³ 20% fluid overload had an 8.5-fold greater adjusted odds ratio of death than those with less than 20% fluid overload (Sutherland et al., 2010) . A recent study by Hassinger et al. (2014) also demonstrated that increasing positive FB, as measured by daily fluid balance, is associated with worse outcome following congenital heart surgery in infants. In the study of Lex et al. (2016) , where postoperative FB was analysed in 1520 paediatric patients after open heart surgery, there was a positive FB between 5% and 10% in 120 patients (7.8%), and in 33 patients (2.1%) FB was above 10%. Multivariable analysis showed that higher fluid overload on the day of the surgery was independently associated with mortality (adjusted odds ratio, 1.14; 95% CI, 1.008-1.303; p = 0.041) and low cardiac output syndrome (adjusted odds ratio, 1.21; 95% CI, 1.12-1.30; p = 0.001). Higher maximum SCys C levels (adjusted odds ratio, 1.01; 95% CI, 1.003-1.021; p = 0.009), maximum vasoactive-inotropic scores (adjusted odds ratio, 1.01; 95% CI, 1.005-1.029; p = 0.042), and higher blood loss on the day of the surgery (adjusted odds ratio, 1.01; 95% CI, 1.004-1.025; p = 0.015) were associated with a higher risk of fluid overload that was greater than 5% (Lex et al., 2016) .
The etiology of positive FB in this patient population is multifactorial. Cardiopulmonary bypass results in both haemodilution and increased capillary permeability, both of which promote extravasation of fluid into the extracellular fluid compartment (Zhang et al., 2004) . Fluid resuscitation and blood product administration in the immediate postoperative period further contributes to third spacing. As body wall oedema increases, intra-abdominal pressure rises and renal perfusion pressure is decreased (Wauters et al., 2009) . When combined with postoperative myocardial dysfunction, there is also a stimulus to retain fluid via the renin-angiotensin-aldosterone system (Sorof et al., 1999) . Given the acute nature of CPB mediated kidney injury and the observation that most infants have normal renal function prior to surgery, these patients may be ideal candidates for aggressive postoperative goal-directed protocols aimed at minimisation of positive FB. Peritoneal dialysis has been shown to be a safe and effective method of fluid removal in postcardiotomy infants (Pedersen et al. 2008) , and early initiation of this therapy can improve haemodynamics and ICU outcomes (Sorof et al., 1999) .
By examining fluid balance early after cardiac surgery, the current study adds to the growing body of evidence that positive fluid balance is independently associated with kidney dysfunction. FB POD-1 ³ 50 ml/kg, in the non-AKI group was 35.29% versus 59.52% in AKI group, p = 0.046 (Table 4) . Median postoperative fluid balance in the non-AKI group was 13.58 ml/kg versus 27.20 ml/kg in the AKI group, p = 0.025 (Table 4 , Fig. 5 ), OR of FB ³ 50 ml/kg in AKI vs. non-AKI was 2.58 (CI 95% 0.94-7.07), p = 0.026. After performing ROC analysis, AUC of FB POD-1 was 0.842 with sensitivity of 80%, specificity of 71% (CI 95% 0.838-0.926) and cut-off value was 25 ml/kg, p = 0.001 (Fig. 7) . Similar results were published in the study of Hassinger et al. (2014) . They found postoperative positive fluid balance > 50 ml/kg in 31% of patients, which is less than in this study. The reported AUC was 0.963; 95% CI, 0.916-1.000; p = 0.002 (Hassinger et al., 2014) .
CONCLUSIONS
Fluid balance is a suitable marker for the prediction of postoperative AKI. 35.29% patients had FB POD-1 ³ 50 ml/kg in the non-AKI group had versus 59.52% in the AKI group, p = 0.046. Median postoperative fluid balance in the non-AKI group was 13.58 ml/kg versus 27.20 ml/kg in the AKI group, p = 0.025, OR of FB ³ 50 ml/kg in AKI versus non-AKI was 2.58 (CI 95% 0.94-7.07), p = 0.06. After performing ROC analysis, AUC of FB POD-1 was 0.842 with sensitivity of 80%, specificity of 71% (CI 95% 0.838-0.926) and the cut-off value was 25 ml/kg, p = 0.001. The role of fluid balance in the postoperative management is underestimated and daily FB monitoring now becomes essential.
